YHYasunobu Hayabuchi

Yasunobu Hayabuchi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yasunobu Hayabuchi has a total of 299 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Novel analytical application of the pressure phase plane for evaluating pulmonary artery wave reflection in surgically repaired tetralogy of Fallot

    by Yasunobu Hayabuchi, Yukako Homma

    Background: Pulmonary artery (PA) wave reflection is a key determinant of right ventricular (RV) afterload. RV function is the most important factor determining long-term prognosis in patients with surgically repaired tetralogy of Fallot (rTOF). This study aimed to evaluate PA wave reflection in rTOF using RV pressure phase plane (PPP) analysis, and to identify the clinical, morphological, and hemodynamic characteristics associated with increased PA wave reflection in patients with rTOF. Methods: Augmentation pressure (AugPr) during late systole was quantified using the inflection point of systolic dP/dt on the PPP. The ratio of AugPr to RV systolic pressure (RVSP) was defined as the AugPr index. The study included 87 patients with rTOF (mean age, 15.9 ± 10.0 years), 17 control subjects (13.3 ± 6.3 years), and seven patients with pulmonary arterial hypertension (PAH) (16.4 ± 11.7 years). The rTOF cohort was categorized according to surgical procedure: pulmonary valve–sparing repair (PVS, n = 5), transannular patch repair (TAP, n = 34), and the Rastelli procedure (n = 48). Results: The prevalence of AugPr was 0% in the control group, 100% in the PAH group, and 26.4% in the rTOF group (p < 0.0001). Among the surgical subgroups, the prevalence was 0% in PVS, 14.7% in TAP, and 41.7% in the Rastelli group (p < 0.0027). AugPr and the AugPr index were significantly higher in the Rastelli group than in the other two groups (p = 0.0447 and 0.0433, respectively). In addition, AugPr showed significant correlations with RVSP, RV outflow tract obstruction, maximal dP/dt, and pulmonary regurgitation grade (all p < 0.05). Conclusions: PA wave reflection can be clearly visualized using PPP. The Rastelli group demonstrated a higher prevalence and magnitude of PA wave reflection, suggesting a greater increase in RV afterload compared with other surgical repair types.

  • Open Access

    Unplanned Hospitalization Due to All‐Cause Morbidity and Its Real‐World Management Practices in Patients With Fontan Circulation

    by Hideo Ohuchi, Kohta Takei, Jun Muneuchi, Shingo Kasahara, Yuichi Ishikawa, Shota Muraji, Masanori Tsukada, Masaki Nii, Shin Ono, Motoki Takamuro, et al.

    Background: Management strategies of unplanned hospitalizations (UPH) vary and have not been well characterized in patients with Fontan circulation. Methods: We prospectively followed 3226 Fontan patients for 3 years to characterize the current UPH status and elucidate the associations between in‐hospital management strategies and postdischarge outcomes. Results: A total of 243 UPHs occurred (2.5 cases/100 person‐years). Fontan‐related UPHs accounted for 154 cases (63%), most commonly due to heart failure (19%), protein‐losing enteropathy (16%), hemorrhage (14%), arrhythmia (9%), thromboembolism (3%), and plastic bronchitis (2%). Fontan‐unrelated UPHs (89 cases; 37%) were mainly due to infections (19%). Adult patients were more frequently hospitalized for hemorrhage and thromboembolism ( P P <0.01–0.001). Conclusions: We clarified real‐world practices related to UPHs in Fontan patients. Specific in‐hospital treatment strategies were associated with the risk of readmission. Further studies are warranted to determine the causal relationships between treatment approaches and outcomes for standardized management strategies.


  • Open Access

    A case of Baraitser–Winter cerebrofrontofacial syndrome diagnosed by whole-exome sequencing

    by Kenichi Suga, Hiroki Sato, Masashi Suzue, Yukako Honma, Yasunobu Hayabuchi, Ryuji Nakagawa, Kayo Shinomiya, Nobuhiko Okamoto, Yuta Inoue, Naomi Tsuchida, et al.

    Here we report a heterozygous missense variant in the ACTB gene, NM_001101.5:c.209C>T (p.Pro70Leu), detected in a case of a mildly affected infant with Baraitser–Winter cerebrofrontofacial syndrome, characterized by unique craniofacial features, coloboma and mild developmental delay, but without lissencephaly. Baraitser–Winter cerebrofrontofacial syndrome cases with a similar mild phenotype have been reported to have the same variant in different populations, suggesting a genotype–phenotype correlation in this syndrome.

  • Open Access

    Diuretics in the Treatment of Heart Failure Due to Congenital Heart Disease

    by Yasunobu Hayabuchi

    左右短絡性先天性心疾患を中心とした乳児心不全における治療は利尿薬の投与から始まる.利尿薬の使用に際しては,腎臓の構造,ネフロン・腎小体・尿細管の機能,傍糸球体装置からのレニン分泌とレニン・アンジオテンシン・アルドステロン(RAA)系の制御,対向流メカニズム・腎神経・緻密斑・尿細管糸球体フォードバックなどの機序を理解することが循環動態への影響を把握するという観点から望ましい.ほとんどの心不全薬には大規模臨床試験によるエビデンスが存在しているが,利尿薬に関しては十分な臨床試験からの確立されたエビデンスは存在しない.また,慢性心不全では利尿薬の使用量が多いほど予後が悪いことも報告されている.非代償性心不全・利尿薬抵抗性の症例にどのように利尿薬を使用するのが予後改善に有効かという臨床的問題には不明な点が未だ多く残されている.本総説では腎臓の構造と機能を説明したのちに利尿薬の種類・作用機序・副作用について解説していく.さらにループ利尿薬に焦点を当てて慢性心不全における利尿薬抵抗性に関する注意点について述べることとする.

  • Open Access

    Characterization of Intracardiac Flow in the Right Ventricle With Pressure and Volume Overload in Children

    by Yasunobu Hayabuchi, Yukako Homma

    Background: Blood flow visualization using vector flow mapping (VFM) holds potential as a novel indicator of right ventricular (RV) function. Methods: This study included 12 patients with atrial septal defect (ASD group, mean (± standard deviation) age: 6.2 ± 1.5 years), six patients with pulmonary hypertension (PH group, mean age: 6.8 ± 2.3 years), and 35 healthy, age-matched children (control group, mean age: 7.3 ± 1.6 years). VFM data were obtained from the parasternal RV short-axis view. Results: VFM images in the majority of the control group showed a counterclockwise rotating vortex below the tricuspid anterior leaflet and clockwise vortex below the septal leaflet in early diastole. In late diastole, a clockwise vortex flow appeared at the RV apex to the outflow tract. In the ASD and PH groups, the formation of vortical flow below the tricuspid valve was decreased. Late-diastolic vortices also differed from the control group, with counterclockwise or no vortex flow seen in this phase in these groups. Flow energy loss (EL), kinetic energy (KE) and energetic performance index (EPI) were related to RV systolic and diastolic functions. Mean EL over one cardiac cycle (ELcycle) was significantly higher in the PH group than in the control group (P = 0.0471). KE of the RV inflow tract (KE-RVin) and outflow tract (KE-RVout) were significantly lower in the PH group than in the control and ASD groups (P < 0.05 each). Conclusions: These results suggest that RV vortex formation may be a factor in efficient ejection. EL, KE, and EPI may be applicable to evaluate RV contractility and diastolic function.


  • Open Access

    Determination of Genotype and Phenotypes in Pediatric Patients With Biventricular Noncompaction

    by Keiichi Hirono, Yukiko Hata, Teruhiko Imamura, Kaori Tsuboi, Shinya Takarada, Mako Okabe, Hideyuki Nakaoka, Keijiro Ibuki, Sayaka Ozawa, Shojiro Ichimata, et al.

    Background: Left ventricular noncompaction (LVNC) is a hereditary type of cardiomyopathy characterized by prominent trabeculations. Detailed characteristics of biventricular noncompaction (BiVNC) remain unknown. This study aimed to elucidate the clinical characteristics and genetic landscape of BiVNC. Methods and Results: We recruited children with left ventricular noncompaction from Japanese multi‐institutional centers from 2013 to 2021. Left ventricular noncompaction was classified as BiVNC, congenital heart disease, arrhythmia, dilated cardiomyopathy, or normal function. In these patients, cardiomyopathy‐associated genes were screened. A total of 234 patients (127 male; mean age, 4 months [range, 0–6.6 years]) were enrolled in this study, of whom 25 had BiVNC; 55, normal function; 84, dilated cardiomyopathy; 38, congenital heart disease; and 32, arrhythmia. BiVNC was diagnosed during the perinatal period in 10 patients, in whom the prevalence was higher than that in other patients. A total of 14 patients in the group with BiVNC had congenital heart disease, but not necessarily right heart lesions. Left ventricular dyskinesis was frequently observed in the lateral wall (24%) and apex (28%). Eleven pathogenic variants were found in 11 patients with BiVNC (44.0%). The group with BiVNC had a higher ratio of mitochondrial and developmental gene variants than the other groups. Among all groups, the group with BiVNC had the worst survival rate ( P =0.0009). Conclusions: Pediatric patients with BiVNC had a high rate of ventricular dyskinesis and poor outcome. A comprehensive and careful screening for disease‐causing genes and phenotype may help identify specific patients with left ventricular noncompaction and mortality‐related cardiac phenotypes.


  • Open Access

    Sarcomere gene variants did not improve cardiac function in pediatric patients with dilated cardiomyopathy from Japanese cohorts

    by Keiichi Hirono, Yukiko Hata, Shojiro Ichimata, Naoki Nishida, Teruhiko Imamura, Yoshihiro Asano, Yuki Kuramoto, Kaori Tsuboi, Shinya Takarada, Mako Okabe, et al.

    Background: Dilated cardiomyopathy (DCM) is a progressive myocardial disorder characterized by impaired cardiac contraction and ventricular dilation. Some patients with DCM could manifest improvement in these abnormalities called left ventricular reverse remodeling (LVRR). However, the detailed association between genotypes and clinical outcomes, including LVRR, particularly among pediatric patients, remains uncertain. Methods: We prospectively enrolled pediatric patients with DCM from Japanese multi-institutional centers between 2014 and 2023. We identified DCM-related genes and explored the association between gene variants and clinical outcomes, including LVRR, which was defined as any increase in left ventricular ejection fraction during the observation period. Results: A total of 123 pediatric patients (62 males; mean age of 8 months [range, 1–51 months]) were retrospectively enrolled. There were 50 pathogenic variants in 45 patients (35.0%). The most identified gene was MYH7 (14.0%), followed by RYR2 (12.0%), and TPM1 (8.0%). A novel variant in the CASZ1 gene (NM_001079843.2 c.3356G>A, p. Trp1119Ter) was identified. LVRR was achieved in 47.5% of patients. In patients with sarcomere gene variants, the left ventricular ejection fraction remained unchanged (31.4% to 39.8%, P = 0.1913), whereas it significantly increased in patients with non-sarcomere gene variants (33.4% to 47.8%, P = 0.0466) and in patients without gene variants (33.6% to 54.1%, P = 0.003). Conclusions: Pediatric patients with DCM exhibited a marked genetic heterogeneity with a different landscape from adults with DCM. LVRR was not uniform across functional gene groups, opening the door to tailor-made gene-guided prediction in pediatric patients with DCM. Clinical perspective: What is new?: Younger patients had predominance for DCM and risk factors for survival. LVRR occurrence was lower in the sarcomere gene group, and cardiac function failed to improve. What are the clinical implications?: LVRR was not uniform across functional gene groups, which opens the door to the adoption of an individualized prediction approach in DCM according to the genetic features.

  • Open Access

    Novel large deletion involving EVC and EVC2 in Ellis–van Creveld syndrome

    by Hiroki Sato, Kenichi Suga, Masashi Suzue, Yukako Honma, Yasunobu Hayabuchi, Shunsuke Miyai, Hiroki Kurahashi, Ryuji Nakagawa

    Ellis–van Creveld syndrome is an autosomal recessive skeletal dysplasia that is characterized by thoracic hypoplasia, polydactyly, oral abnormalities, and congenital heart disease. It is caused by pathogenic variants in the EVC or EVC2 genes. We report a case of a newborn with a compound heterozygous variant comprising NM_147127.5: c.1991dup:[p.Lys665Glufs*10] in the EVC2 gene and a novel large deletion involving exon 1 in EVC and exons 1–7 in EVC2.


  • Open Access

    Pathophysiology and Functional Assessment of Right Heart Failure

    by Yasunobu Hayabuchi

    小児循環器領域において右室機能解析を要する場面は多いが,正確な右室機能を測定評価することは簡単ではない.右心不全を呈する病態を分類すると,圧負荷,容量負荷,心筋障害の3つの機序が原因として挙げられるが,実際には様々な程度でこれらは混在することが多い.これらのうち右室機能障害の最も重要な原因は肺高血圧症であり,圧負荷に対する右室機能解析は同疾患の予後規定因子として評価が重要であるというだけではなく,右室機能障害を来す他疾患への応用と右室挙動の普遍的な解析のための基軸研究となり得る点で意義深い. 本総説では正常右室の構造・機能を解説したのち,右室機能障害の評価方法について説明する.右室機能障害は,右室全体の収縮機能の変化だけでなく,収縮様式,右室-肺動脈カップリング,同期性,心室間相互作用,拡張能などの障害も含んでいることを解説していく.

  • Open Access

    Molecular diagnosis of an infant with TSC2/PKD1 contiguous gene syndrome

    by Keita Osumi, Kenichi Suga, Akemi Ono, Aya Goji, Tatsuo Mori, Yukiko Kinoshita, Mikio Sugano, Yoshihiro Toda, Maki Urushihara, Ryuji Nakagawa, et al.

    A 1-month-old Japanese infant with cardiac rhabdomyoma was diagnosed with TSC2/PKD1 contiguous gene syndrome by targeted panel sequencing with subsequent quantitative polymerase chain reaction that revealed gross monoallelic deletion, including parts of two genes: exons 19–42 of TSC2 and exons 2–46 of PKD1. Early molecular diagnosis can help to detect bilateral renal cyst formation and multidisciplinary follow-up of this multisystem disease.